<p>A conjugable selective CB2 receptor ligand capable of targeted delivery, allowing for methods of targeted disease imaging and/or targeted disease treatment using a receptor ligand of the present invention. Additional aspects are method of invention is imaging a molecular event comprising administering a conjugate of the present invention.</p>
